GPCR Safety Assessment Screening
Reducing costly safety-related attrition.
Identification of undesirable off-target effects is an essential process in any drug discovery campaign. In vitro pharmacological profiling against a broad panel of known potential hazards at an early stage in the discovery process can therefore aid decision-making in lead generation, lead optimization and candidate selection, resulting in significantly reduced downstream safety-related attrition.
SB’s GPCR safety assessment panel provides a broad pharmacological profile of your compounds and their potential to cause adverse drug reactions. Our flexible service allows you to screen against the complete panel or select only the targets that matter to you.
GPCR Safety Panel
|Receptor||Species||Ligand Binding||Cell-Based Assay|